Aarey Drugs & Pharmaceuticals Limited
Disclosure under SEBI Takeover Regulations
Aarey Drugs & Pharmaceuticals Limited has submitted a disclosure under SEBI Takeover Regulations, indicating a potential takeover or acquisition activity.
23
total announcements
AAREYDRUGS.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 21 Oct 2026
Market Cap
₹363 Cr
P/E (TTM)
77.5
EPS (TTM)
₹1.47
52W Low
₹50.31
52W High
₹114.80
Dividend Yield
0.00%
Beta
1.24
Price / Book
2.2
Debt / Equity
40.4
Revenue (TTM)
₹415 Cr
Gross Margin
3.82%
Operating Margin
1.07%
Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited has submitted a disclosure under SEBI Takeover Regulations, indicating a potential takeover or acquisition activity.
Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited has submitted a disclosure under SEBI Takeover Regulations, as per Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.